Stay updated with breaking news from Lexaria Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lexaria Bioscience Corp. (NASDAQ:LEXX – Get Rating) was the recipient of a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 343,000 shares, an increase of 31.9% from the May 15th total of 260,100 shares. Currently, 4.7% of the shares of the company are sold […]
Lexaria Bioscience Corp. (NASDAQ:LEXX – Get Rating) was the recipient of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 343,000 shares, a growth of 31.9% from the May 15th total of 260,100 shares. Approximately 4.7% of the company’s shares are short sold. Based […]
KELOWNA, BC / ACCESSWIRE / June 12, 2023 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the appointment of
Lexaria Bioscience's powerful, proprietary drug delivery technology, DehydraTECH has the potential to disrupt multiple categories as the company continues to receive positive results from clinical... | June 7, 2023
Lexaria Bioscience Corp. (NASDAQ:LEXX – Get Rating)’s share price traded up 13.2% during mid-day trading on Tuesday . The stock traded as high as $0.88 and last traded at $0.78. 1,658,700 shares changed hands during trading, an increase of 1,683% from the average session volume of 93,028 shares. The stock had previously closed at $0.69. […]